Atin Tomar

Atin brings with him comprehensive experience in the biotechnology industry especially in the areas of vaccines and biologics. Atin’s expertise spans from process development, scale-up, technology transfer and manufacturing operations to business development, licensing and commercialization.

Prior to joining CPL Biologicals, Atin was associated with the iotechnology industry in various roles. He was involved in the development of biologics/bio-therapeutics from the early stages of development to commercial manufacturing at Human Genome Sciences Inc., Amgen Inc. and Syngene International Limited (aBiocon Company). At Dr. Reddy’s Laboratories Ltd., MSD Wellcome Trust Hilleman Laboratories Pvt. Ltd. and International Vaccine Institute (IVI).Atin was involved in Business Development & Licensing, Partnerships and Collaborations, Program Management, Alliance Management and Commercialization for Biosimilars and Vaccines.

Atin completed his BTech (Hons) in Biotechnology and Biochemical Engineering from the Indian Institute of Technology (IIT) Kharagpur, India, MS in Biological Engineering from the University of Georgia, Athens, USA and Post-Graduate Programme in Management (MBA) in Finance and Strategy & Leadership from the Indian School of Business (ISB), Hyderabad, India.